This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why Wait With Prostate Cancer When You Can Enjoy Life Cancer-Free?

NEW YORK, Nov. 9, 2012 /PRNewswire/ -- Men are presented with many options when it comes to protecting their prostates. From the prostate-specific antigen (PSA) blood test, to active surveillance, to prostate cancer treatments, decisions abound. Those who are diagnosed with prostate cancer – typically through a PSA test, digital rectal exam (DRE), and prostate biopsy – must then decide whether or not to act.

(Photo: )

David Samadi, MD, world-renowned SMART (Samadi Modified Advanced Robotic Technique) robotic prostate removal surgeon, works closely with each patient following diagnosis. Helping patients decide how to handle their prostate cancer, he believes, is a balance of medical research and personal wellbeing. "Active surveillance is a difficult recommendation to make to an otherwise healthy man," says Dr. Samadi. "With robotic prostatectomy surgery I have the means to help them overcome prostate cancer. If I tell them to wait, they go home worried and potentially at risk."

Prostate Cancer:  Spread Without SymptomsA new prostate cancer study from the University of Gothenburg, Sweden, published this September in the journal European Urology, found that 63 percent of men could go six years beyond diagnosis before needing treatment. "Could doesn't necessarily mean should," said Dr. Samadi who educates patients about the limits of prostate cancer diagnostics in predicting disease progression.

"So much is made of men living symptom-free with prostate cancer," says Dr. Samadi. "But that's a problem, not a benefit. Without symptoms it's easy for men to assume everything is fine, they may skip an appointment or two. But prostate cancer is a master of stealth growth and waiting can be dangerous."

Watchful Waiting or Watchful Worry ?

Interestingly, almost 40 percent of participants in the Swedish study opted for treatment rather than surveillance, either because their tumor showed signs of growth or they chose not to live with the constant worry. "Beyond the science, there's a strong emotional consideration," added Dr. Samadi. "If you're diagnosed with prostate cancer at 65, do you want to spend the next 20+ years in watchful worry?"

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.55 -0.74%
FB $118.59 0.66%
GOOG $706.99 0.79%
TSLA $212.70 0.55%
YHOO $36.84 -0.26%


Chart of I:DJI
DOW 17,655.00 -5.71 -0.03%
S&P 500 2,044.00 -6.63 -0.32%
NASDAQ 4,695.8940 -21.20 -0.45%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs